×
  1. Home
  2. News

China National Drug Administration 3 Stipulation Scheme Unveiled

  •   14 Aug 2018
  •    Hedy He
  •  553
  •   Post a comment

    China National Drug Administration 3 Stipulation Scheme Unveiled3 Stipulation Scheme clarifies the responsibilities and division of labor between the newly formed SAMR and subordinate CNDA departments. A Cosmetic Safety Supervision Department is newly established. Compliance requirements mandating registration of all imported non-special use cosmetics will be gradually phased out and replaced by new filing requirements. Classified management will be implemented on new cosmetic ingredients...

    You are a visitor, Please login.

    Share this:

    ABOUT THE AUTHOR

    ChemLinked Editor

    Tracking regulatory change news in Asia Pacific area and focusing on cosmetic ingredient requirements, registration/filing/notification procedures of China, Taiwan (district), Korea.

    COPYRIGHT: You may circulate web links to the web and contents, but they are intended for your personal, non-commercial use only. For other use of any materials, you can contact with editor@chemlinked.com to seek consent. Find out more about our copyright policy here.
    CORRECTIONS: we do our best to provide you with accurate information. However sometimes errors slip under the radar. If you notice any errors contact us on: editor@chemlinked.com
    Content sharing or co-authoring: just send messages to our editor team.